Effect of Glucagon-like Peptide-1 Stimulation on Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Obstructive Stenosis of Major Coronary Vessels
Phase of Trial: Phase IV
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms GAP
- 21 Jun 2017 Status changed from recruiting to completed.
- 22 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Oct 2015 New trial record